Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Dutch Banks May Be Charged Up to $85 Million for Health Checks

March 21 (Bloomberg) -- The Dutch central bank plans to charge six lenders, including ING Groep NV and Rabobank Groep, as much as 61.7 million euros ($85 million) for costs it will incur in performing health checks ordered by the European Central Bank.

The exams, including an asset quality review, stress test and risk analysis, will lead to costs of between 42.5 million euros and 61.7 million euros, the Amsterdam-based central bank said in a letter to the Dutch finance ministry dated March 20. The costs will be passed to the banks under review, according to the letter published on the ministry’s website today.

Based on information gathered from other supervisors, the estimate is “relatively comparable to the costs in some other countries with significant banking industries,” the central bank said. The ECB is preparing to take over banking supervision in November.

The Dutch regulator said it was difficult to compare costs as countries are reluctant to share the information and there are differences in the scope of the reviews and internal staff that can be assigned. To restrain the financial burden, the Dutch central bank agreed with the ECB to limit the maximum number of loan portfolios and credit files to be reviewed, while ensuring the probe offers sufficient certainty.

In the Netherlands, more than 90 percent of the industry will fall under direct ECB oversight. ING Groep’s banking arm, Rabobank and ABN Amro Group NV, the three biggest Dutch lenders, will be probed, as well as SNS Reaal NV’s banking unit, Bank Nederlandse Gemeenten, Nederlandse Waterschapsbank NV and Royal Bank of Scotland NV.

The range in potential costs results from “uncertainties” in the project, including the number of credit files to be reviewed and collateral assessed, the central bank said.

To contact the reporters on this story: Maud van Gaal in Amsterdam at; Martijn van der Starre in Amsterdam at

To contact the editors responsible for this story: Frank Connelly at; Mariajose Vera at Cindy Roberts

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.